The stock of eyecare company Bausch + Lomb Corp. was up 14%on Monday, after the Financial Times reported that the company is considering selling itself as a way to extricate itself from its ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of their value on a report that a joint takeover bid for the group is in trouble. The Financial Times has said that ...

Bausch, which has been working to sell its profitable eye-care business Bausch + Lomb and refinance debt, tapped bankers from Evercore Inc. to advise it on financial options, according to people ...